Skip to main content

Illumina Gets $17M Contract from FDA for Food Safety Tools

NEW YORK (GenomeWeb News) – Illumina today said that it has received a $17 million contract from the US Food and Drug Administration to provide sequencing systems and reagents for food safety testing.

Under the five-year contract, Illumina will supply its MiSeq systems and reagents for performing whole-genome analysis on produce and produce-related environmental Salmonella and shigatoxigenic E. coli isolates.

Illumina said in a statement that the FDA already has several MiSeq systems deployed in its labs and is building its existing capacity as part of a proof-of-concept initiative. In addition, it said in the short-term the FDA is looking to collect data that is crucial to source-tracking Salmonella that may be involved in future produce-related outbreaks.

Sequence data collected at the FDA labs will be uploaded in real-time to the National Center for Biotechnology Information curated database and will provide early proof of concept for using whole-genome sequencing for pathogen detection, identification and traceback, said Illumina.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.